Terms: = Prostate cancer AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb
32 results:
1. Non-pharmacological and nonsurgical interventions in male urinary incontinence: A scoping review.
Zhang Y; Hou S; Qi Z; Wu S; Zhu K; Wang W
J Clin Nurs; 2023 Sep; 32(17-18):6196-6211. PubMed ID: 37161602
[TBL] [Abstract] [Full Text] [Related]
2. Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant prostate cancer.
Blatti C; de la Fuente J; Gao H; Marín-Goñi I; Chen Z; Zhao SD; Tan W; Weinshilboum R; Kalari KR; Wang L; Hernaez M
Cancer Res; 2023 Apr; 83(8):1361-1380. PubMed ID: 36779846
[TBL] [Abstract] [Full Text] [Related]
3. Biphasic transcriptional and posttranscriptional regulation of myb by androgen signaling mediates its growth control in prostate cancer.
Acharya S; Anand S; Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP
J Biol Chem; 2023 Jan; 299(1):102725. PubMed ID: 36410437
[TBL] [Abstract] [Full Text] [Related]
4. Post-prostatic-massage urine exosomes of men with chronic prostatitis/chronic pelvic pain syndrome carry prostate-cancer-typical microRNAs and activate proto-oncogenes.
Schneider L; Dansranjav T; Neumann E; Yan H; Pilatz A; Schuppe HC; Wagenlehner F; Schagdarsurengin U
Mol Oncol; 2023 Mar; 17(3):445-468. PubMed ID: 36321189
[TBL] [Abstract] [Full Text] [Related]
5. [High expression of mybL2 promotes progression and predicts a poor survival outcome of prostate cancer].
Yang M; Zhu X; Shen Y; He Q; Qin Y; Shao Y; Yuan L; Ye H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1109-1118. PubMed ID: 36073208
[TBL] [Abstract] [Full Text] [Related]
6. WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.
Kench JG; Amin MB; Berney DM; Compérat EM; Cree IA; Gill AJ; Hartmann A; Menon S; Moch H; Netto GJ; Raspollini MR; Rubin MA; Tan PH; Tsuzuki T; Turjalic S; van der Kwast TH; Zhou M; Srigley JR
Histopathology; 2022 Oct; 81(4):447-458. PubMed ID: 35758185
[TBL] [Abstract] [Full Text] [Related]
7. Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism.
Chen L; Song Y; Hou T; Li X; Cheng L; Li Y; Xing Y
J Exp Clin Cancer Res; 2022 Jun; 41(1):194. PubMed ID: 35659274
[TBL] [Abstract] [Full Text] [Related]
8. myb interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer.
Srivastava SK; Khan MA; Anand S; Zubair H; Deshmukh SK; Patel GK; Singh S; Andrews J; Wang B; Carter JE; Singh AP
Br J Cancer; 2022 May; 126(8):1205-1214. PubMed ID: 34837075
[TBL] [Abstract] [Full Text] [Related]
9. mybL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
Li Q; Wang M; Hu Y; Zhao E; Li J; Ren L; Wang M; Xu Y; Liang Q; Zhang D; Lai Y; Liu S; Peng X; Zhu C; Ye L
Theranostics; 2021; 11(12):5794-5812. PubMed ID: 33897882
[No Abstract] [Full Text] [Related]
10. Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report.
Williams SG; Aw Yeang HX; Mitchell C; Caramia F; Byrne DJ; Fox SB; Haupt S; Schittenhelm RB; Neeson PJ; Haupt Y; Keam SP
BMC Urol; 2020 Oct; 20(1):171. PubMed ID: 33115461
[TBL] [Abstract] [Full Text] [Related]
11. myb-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia.
Magers MJ; Iczkowski KA; Montironi R; Grignon DJ; Zhang S; Williamson SR; Yang X; Wang M; Osunkoya AO; Lopez-Beltran A; Hes O; Eble JN; Cheng L
Mod Pathol; 2019 Nov; 32(11):1666-1674. PubMed ID: 31189999
[TBL] [Abstract] [Full Text] [Related]
12. Arsenic Alters Exosome Quantity and Cargo to Mediate Stem Cell Recruitment Into a cancer Stem Cell-Like Phenotype.
Ngalame NNO; Luz AL; Makia N; Tokar EJ
Toxicol Sci; 2018 Sep; 165(1):40-49. PubMed ID: 30169766
[TBL] [Abstract] [Full Text] [Related]
13. A subset of prostatic basal cell carcinomas harbor the myb rearrangement of adenoid cystic carcinoma.
Bishop JA; Yonescu R; Epstein JI; Westra WH
Hum Pathol; 2015 Aug; 46(8):1204-8. PubMed ID: 26089205
[TBL] [Abstract] [Full Text] [Related]
14. miR-204 is dysregulated in metastatic prostate cancer in vitro.
Todorova K; Metodiev MV; Metodieva G; Zasheva D; Mincheff M; Hayrabedyan S
Mol Carcinog; 2016 Feb; 55(2):131-47. PubMed ID: 25630658
[TBL] [Abstract] [Full Text] [Related]
15. Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress.
Chen Y; Zhang Z; Yang K; Du J; Xu Y; Liu S
Oncogene; 2015 Jul; 34(29):3839-47. PubMed ID: 25284586
[TBL] [Abstract] [Full Text] [Related]
16. Targeting poly(ADP-ribose) polymerase and the c-myb-regulated DNA damage response pathway in castration-resistant prostate cancer.
Li L; Chang W; Yang G; Ren C; Park S; Karantanos T; Karanika S; Wang J; Yin J; Shah PK; Takahiro H; Dobashi M; Zhang W; Efstathiou E; Maity SN; Aparicio AM; Li Ning Tapia EM; Troncoso P; Broom B; Xiao L; Lee HS; Lee JS; Corn PG; Navone N; Thompson TC
Sci Signal; 2014 May; 7(326):ra47. PubMed ID: 24847116
[TBL] [Abstract] [Full Text] [Related]
17. Integrative genomic analyses of the histamine H1 receptor and its role in cancer prediction.
Wang M; Wei X; Shi L; Chen B; Zhao G; Yang H
Int J Mol Med; 2014 Apr; 33(4):1019-26. PubMed ID: 24535227
[TBL] [Abstract] [Full Text] [Related]
18. Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2.
Li L; Yang G; Ren C; Tanimoto R; Hirayama T; Wang J; Hawke D; Kim SM; Lee JS; Goltsov AA; Park S; Ittmann MM; Troncoso P; Thompson TC
Mol Oncol; 2013 Jun; 7(3):484-96. PubMed ID: 23333597
[TBL] [Abstract] [Full Text] [Related]
19. myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance.
Srivastava SK; Bhardwaj A; Singh S; Arora S; McClellan S; Grizzle WE; Reed E; Singh AP
Carcinogenesis; 2012 Jun; 33(6):1149-57. PubMed ID: 22431717
[TBL] [Abstract] [Full Text] [Related]
20. Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells.
Zhu H; Pan X; Qi H; Wang X; Hou S; Han B; Liu Z; Xu L
Oncol Rep; 2011 Jan; 25(1):81-90. PubMed ID: 21109961
[TBL] [Abstract] [Full Text] [Related]
[Next]